Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes
EndocrinologiaResumo original em inglês
O que aconteceu
To characterize simplified meal bolus strategies in adults with insulin-treated type 2 diabetes using automated insulin delivery (AID).
In the 2IQP study, a 13-week randomized, controlled trial comparing Control-IQ+ AID to continuation of pre-study insulin regimen with continuous glucose monitoring, 201 participants in the AID arm were classified by meal bolus strategy. Glycemic outcomes were compared to baseline.
O que encontraram
68 participants' meal bolus strategies (33.8%) were classified as Carbohydrate Counting, 79 (39.3%) were classified as Preset Carbohydrate Amounts, 27 (13.4%) were classified as Fixed Insulin Doses, and 27 (13.4%) as Other Methods. All bolus strategies were associated with similar, significant improvements in HbA1c from baseline: -0.9% for Carbohydrate Counting (P < 0.001), -1.1% for Preset Carbohydrate Amounts (P < 0.001), -0.8% for Fixed Insulin Doses (P < 0.001), and -0.9% for Other Methods (P = 0.003). Hypoglycemia rates were low at baseline and remained low for all bolus strategies. As participants gained experience with the Control-IQ+ AID system, more participants opted to use a simplified bolus strategy in the second half of the study compared with the first half (63% vs. 52%).
Por que isso importa
Simplified bolus strategies worked well for adults with type 2 diabetes using Control-IQ+ in the 2IQP trial. All bolus strategies led to substantial HbA1c improvements, without safety concerns.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes
Carol J Levy, Lauren Kanapka, Sue A Brown, Sheryl Marks, Tamara Spaic, Devin W Steenkamp, Virginia S Lu, Peter Zhao, John W Lum, Roy W. Beck et al.
Descritores MeSH
- Hypoglycemic Agents
- Insulin
- Insulin Infusion Systems
- Diabetes Mellitus, Type 2
- Glycated Hemoglobin
- Humans
- Hypoglycemia
- Male
- Middle Aged
- Blood Glucose Self-Monitoring
Veja também
Estudos relacionados
- Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial
- Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
- Efficacy and Safety of Automated Insulin Delivery in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis
- Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysis
- Benefício consistente do controle- QI+ Entrega automática de insulina numa gama de características de adultos com diabetes tipo 2